首页> 外文期刊>Theranostics >Ultra - small Pyropheophorbide - a Nanodots for Near - infrared Fluorescence/Photoacoustic Imaging-guided Photodynamic Therapy
【24h】

Ultra - small Pyropheophorbide - a Nanodots for Near - infrared Fluorescence/Photoacoustic Imaging-guided Photodynamic Therapy

机译:超小型焦泡酰基 - 用于近红外荧光/光声成像引导的光动力治疗的纳米液

获取原文
           

摘要

Rationale : Nanoparticles (NPs) that are rapidly eliminated from the body offer great potential in clinical test. Renal excretion of small particles is preferable over other clearance pathways to minimize potential toxicity. Thus, there is a significant demand to prepare ultra-small theranostic agents with renal clearance behaviors. Method : In this work, we report a facile method to prepare NPs with ultra-small size that show renal clearable behavior for imaging-guided photodynamic therapy (PDT). Pyropheophorbide-a (Pa), a deep red photosensitizer was functionalized with polyethylene glycol (PEG) to obtain Pa-PEG. The prepared NPs formed ultra-small nanodots in aqueous solution and showed red-shifted absorbance that enabling efficient singlet oxygen generation upon light irradiation. Results : In vitro studies revealed good photodynamic therapy (PDT) effect of these Pa-PEG nanodots. Most of the cancer cells incubated with Pa-PEG nanodots were destroyed after being exposed to the irradiated light. Utilizing the optical properties of such Pa-PEG nanodots, in vivo photoacoustic (PA) and fluorescence (FL) imaging techniques were used to assess the optimal time for PDT treatment after intravenous (i.v.) injection of the nanodots. As monitored by the PA/FL dual-modal imaging, the nanodots could accumulate at the tumor site and reach the maximum concentration at 8 h post injection. Finally, the tumors on mice treated with Pa-PEG nanodots were effectively inhibited by PDT treatment. Moreover, Pa-PEG nanodots showed high PA/FL signals in kidneys implying these ultra-small nanodots could be excreted out of the body via renal clearance. Conclusion : We demonstrated the excellent properties of Pa-PEG nanodots that can be an in vivo imaging-guided PDT agent with renal clearable behavior for potential future clinical translation.
机译:理由:从身体迅速消除的纳米颗粒(NPS)在临床试验中提供了很大的潜力。在其他间隙途径上,优选小颗粒的肾脏排泄,以最大限度地减少潜在的毒性。因此,有显着的需求来制备具有肾间隙行为的超小型治疗剂。方法:在这项工作中,我们报告了一种适用的方法,用于制备具有超小尺寸的NPS,显示用于成像引导的光动力治疗(PDT)的肾可清洁行为。用聚乙二醇(PEG)官能化热酚 - A(PA),将深红色光敏剂用聚乙二醇(PEG)官能化,得到PA-PEG。制备的NPS在水溶液中形成超小纳米蛋白,并显示出在光照射时能够有效的单线发出产生的红移吸光度。结果:体外研究揭示了这些PA-PEG纳米蛋白的良好光动力治疗(PDT)效应。在暴露于照射光后,将与Pa-PEG纳米蛋白孵育的大多数癌细胞被破坏。利用这种PA-PEG纳米蛋白的光学性质,在体内光声(PA)和荧光(FL)成像技术中用于评估静脉内(I.V.)注射纳米蛋白后PDT处理的最佳时间。由PA / FL双模态成像监测,纳米蛋白可以在肿瘤部位积聚并在注射后8小时内达到最大浓度。最后,通过PDT处理有效地抑制用PA-PEG纳米蛋白处理的小鼠肿瘤。此外,PA-PEG纳米蛋白在肾脏中显示出高PA / FL信号,暗示这些超小纳米蛋白可以通过肾间隙排出身体。结论:我们证明了PA-PEG纳米蛋白的优异性能,可以是体内成像引导的PDT试剂,具有肾脏可清除性的临床翻译。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号